Modulation of calciuria by cadmium pretreatment in rats with cadmium-metallothionein-induced nephrotoxicity
- PMID: 1360715
- DOI: 10.1016/0300-483x(92)90123-v
Modulation of calciuria by cadmium pretreatment in rats with cadmium-metallothionein-induced nephrotoxicity
Abstract
One group of male Wistar rats (Group B) was pretreated by a daily subcutaneous injection with CdCl2 during 5 days with increasing doses (0.5, 1, 1, 2 and 2 mg Cd/kg). Another group of rats (Group A) was daily given normal saline subcutaneously for 5 days. On the second day after the last injection, a single s.c. injection of 109Cd-metallothionein (CdMT, 0.4 mg Cd/kg) was given to each animal in both groups. Urinary calcium, protein, metallothionein (MT), N-acetyl-beta-D-glucosaminidase (NAG) and gamma glutamyltransferase (gamma-GT) were measured. In Group A, calciuria, proteinuria, metallothioneinuria and enzymuria was induced by CdMT. Calciuria reached a peak during 0-6 h after the administration of CdMT, thus appearing earlier than other effects. Enzymuria was displayed at 6-12 h for gamma-GT and 12-24 h for NAG. A prominent increase of proteinuria appeared at 24-48 h after the challenge of CdMT. In Group B, no significant increase of urinary calcium, protein, or NAG was observed after the CdMT injection and urinary gamma-GT was only slightly elevated, thus demonstrating the protective action of pretreatment. This study demonstrates for the first time that calciuria, one of the signs of cadmium nephrotoxicity, can be prevented by cadmium pretreatment. Urinary MT increased slightly during the 4-5 days of CdCl2 pretreatment. This is in accordance with previous observations that cadmium pretreatment induces new synthesis of MT which is likely to constitute the background for the resistance to the CdMT challenge to the kidney.
Similar articles
-
Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.Toxicol Appl Pharmacol. 1998 Nov;153(1):48-58. doi: 10.1006/taap.1998.8506. Toxicol Appl Pharmacol. 1998. PMID: 9875299
-
Resistance to acute nephrotoxicity induced by cadmium-metallothionein dependence on pretreatment with cadmium chloride.Pharmacol Toxicol. 1987 Aug;61(2):89-93. doi: 10.1111/j.1600-0773.1987.tb01781.x. Pharmacol Toxicol. 1987. PMID: 3671331
-
Metallothionein protects against the nephrotoxicity produced by chronic CdMT exposure.Toxicol Sci. 1999 Aug;50(2):221-7. doi: 10.1093/toxsci/50.2.221. Toxicol Sci. 1999. PMID: 10478858
-
Nephrotoxic impact of multiple short-interval cadmium-metallothionein injections in the rat.Toxicology. 1996 Aug 16;112(2):151-6. doi: 10.1016/0300-483x(96)03359-8. Toxicology. 1996. PMID: 8814344
-
Modulation of metal toxicity by metallothionein.Biol Trace Elem Res. 1989 Jul-Sep;21:131-5. doi: 10.1007/BF02917245. Biol Trace Elem Res. 1989. PMID: 2484579 Review.
Cited by
-
Using expression profiling to understand the effects of chronic cadmium exposure on MCF-7 breast cancer cells.PLoS One. 2013 Dec 20;8(12):e84646. doi: 10.1371/journal.pone.0084646. eCollection 2013. PLoS One. 2013. PMID: 24376830 Free PMC article.
-
Subcellular targets of cadmium nephrotoxicity: cadmium binding to renal membrane proteins in animals with or without protective metallothionein synthesis.Environ Health Perspect. 1994 Sep;102 Suppl 3(Suppl 3):191-4. doi: 10.1289/ehp.94102s3191. Environ Health Perspect. 1994. PMID: 7843096 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous